Blogs | MedChemExpress

Geptanolimab (CBT-501) is a Anti-PD-1 Monoclonal Antibody for Solid Tumor Research

Geptanolimab (CBT-501) is a programmed death-1 (PD-1) monoclonal antibody. Geptanolimab can be used in research forsolid tumor research.
MC2590, a Potent HDAC Inhibitor, inhibits HDAC1-3, -6, -8, and -10

MC2590 is a potent pyridine-containing HDAC inhibitor and modulates pro- and anti-apoptotic microRNAs toward apoptosis induction.
YX-2-107, a PROTAC and a Selective CDK6 Degrader

YX-2-107 is a PROTAC that selectively degrades CDK6.
Mogamulizumab is a Defucosylated Anti-CCR4 Monoclonal Antibody

Mogamulizumab is an Anti-CCR4 monoclonal antibody. It enhances antibody-dependent cellular cytotoxicity and is effective against leukemia.
Spiruchostatin A is a Potent HDAC Inhibitor with anticancer activity

Spiruchostatin A is a potent HDAC inhibitor that can induce apoptosis and has anticancer activity uesd for leukemia studies.
Abexinostat is an Orally Available Pan-HDAC Inhibitor

Abexinostat, a potent and broad-spectrum inhibitor of histone deacetylases, can be used for the research of cancer.
BNS-22 is a DNA Topoisomerase II Catalytic Inhibitor

BNS-22 is a potent and selective inhibitor of TOP2α and TOP2β that exhibits anti-proliferative activities.
Seliciclib (Roscovitine) is an Orally Active and Selective CDKs Inhibitor

Seliciclib, a potent, selective and orally active CDKs inhibitor, preferentially inhibits CDK2, CDK7 and CDK9.
Chelerythrine is a Potent Protein kinase C Inhibitor

Chelerythrine is a potent inhibitor pf protein kinase C with anti-cancer activity.
HM43239 is an Orally Active and Selective FLT3 Inhibitor

HM43239 is a potent, selective, and orally active FLT3 inhibitor and shows effectiveness in AML with FLT3 mutations.

Name
Email *

	Sorry, but the email address you supplied was invalid.

Blogs (54)